Page 1 of 1

2022-An et al-preprint

PostPosted: Fri Dec 09, 2022 5:53 pm
by mleipold
"Discovery of a novel monoclonal PD-L1 antibody H1A that promotes T-cell mediated tumor killing activity in renal cell carcinoma"
Zesheng An, Michelle A Hsu, Joanina K Gicobi, Tianxiao Xu, Susan M Harrington, Henan Zhang, Kevin D Pavelko, Jacob B Hirdler, Christine Lohse, Reza Nabavizadeh, Rodriguo R Pessoa, Vidit Sharma, R Houston Thompson, Bradley C Leibovich, Haidong Dong, Fabrice Lucien
bioRxiv, posted December 08, 2022
https://doi.org/10.1101/2022.09.10.507426

-will update when/if this is peer-reviewed and published

- no dataset accession given

Re: 2022-An et al-preprint

PostPosted: Wed May 10, 2023 5:06 pm
by mleipold
Now published:

J Immunol. 2023
https://doi.org/10.4049/jimmunol.2200933